NCT00649181View on ClinicalTrials.gov

Fasting Study of Metolazone Tablets 5 mg and Zaroloxyn® Tablets 5 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions
Healthy
Interventions
DRUG

Metolazone Tablets 5 mg

2x5mg, single dose fasting

DRUG

Zaroloxyn® Tablets 5 mg

2x5mg, single dose fasting

Trial Locations (1)

26505

Kendle International Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY